1. Home
  2. MBOT vs LRE Comparison

MBOT vs LRE Comparison

Compare MBOT & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • LRE
  • Stock Information
  • Founded
  • MBOT 2010
  • LRE 2001
  • Country
  • MBOT United States
  • LRE Japan
  • Employees
  • MBOT N/A
  • LRE N/A
  • Industry
  • MBOT Medical/Dental Instruments
  • LRE
  • Sector
  • MBOT Health Care
  • LRE
  • Exchange
  • MBOT Nasdaq
  • LRE Nasdaq
  • Market Cap
  • MBOT 32.7M
  • LRE 29.9M
  • IPO Year
  • MBOT N/A
  • LRE 2023
  • Fundamental
  • Price
  • MBOT $1.99
  • LRE $1.69
  • Analyst Decision
  • MBOT Strong Buy
  • LRE
  • Analyst Count
  • MBOT 1
  • LRE 0
  • Target Price
  • MBOT $7.00
  • LRE N/A
  • AVG Volume (30 Days)
  • MBOT 7.1M
  • LRE 13.5K
  • Earning Date
  • MBOT 11-13-2024
  • LRE 01-01-0001
  • Dividend Yield
  • MBOT N/A
  • LRE N/A
  • EPS Growth
  • MBOT N/A
  • LRE N/A
  • EPS
  • MBOT N/A
  • LRE 0.29
  • Revenue
  • MBOT N/A
  • LRE $117,804,154.00
  • Revenue This Year
  • MBOT N/A
  • LRE N/A
  • Revenue Next Year
  • MBOT N/A
  • LRE N/A
  • P/E Ratio
  • MBOT N/A
  • LRE $5.72
  • Revenue Growth
  • MBOT N/A
  • LRE 8.82
  • 52 Week Low
  • MBOT $0.82
  • LRE $1.19
  • 52 Week High
  • MBOT $3.38
  • LRE $13.76
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 59.53
  • LRE 41.39
  • Support Level
  • MBOT $1.59
  • LRE $1.68
  • Resistance Level
  • MBOT $1.91
  • LRE $1.80
  • Average True Range (ATR)
  • MBOT 0.44
  • LRE 0.15
  • MACD
  • MBOT -0.01
  • LRE -0.01
  • Stochastic Oscillator
  • MBOT 39.57
  • LRE 27.46

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: